FDA Adverse Event Death Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 1711707 · Received June 3, 2010

Report

Report Number
2953200-2010-01012
Event Type
Death
Date Received
June 3, 2010
Date of Event
October 12, 2013
Report Date
January 27, 2014
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4)

Additional Manufacturer Narrative · 1

(B) (4). RESULTS: MI.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT SUFFERED CARDIOPULMONARY ARREST APPROX 58 MONTHS POST INDEX PROCEDURE AND EXPIRED. IT HAS NOT BEEN ASSESSED IF THE DEATH WAS RELATED TO THE STUDY DEVICE.

Description of Event or Problem · 1

EVENT WAS IDENTIFIED BY THE CLINICAL EVENTS COMMITTEE AND DEEMED TO BE CONSISTENT WITH AN MI. PATIENT HAD ONE LESION TREATED DURING INDEX PROCEDURE. TWO ENDEAVOR SPRINT RX DRUG-ELUTING STENTS WERE IMPLANTED (OVERLAPPING) TO MID LCX (REF MFR# 2953200-2010-01011). IT WAS REPORTED THAT AN MI OCCURRED ONE DAY POST STENT IMPLANT. MI WAS CATEGORIZED AS A NON Q WAVE MI, IN THE TERRITORY OF THE IMPLANTED STENT. NO FURTHER DETAILS ARE AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA 0000810236

Patients

Seq Age Sex Outcome Treatment
1 74 YR Death| H CLOPIDOGREL AND ASPIRIN.